This invention relates to methods for treating cardiovascular disorders selected from heart failure, thromboembolic disorders, venous diseases, and fibriotic disorders other than fibrosis of the liver, comprising administering an effective amount of a compound of formula (I) ##STR00001## wherein the several variables are as defined in the specification and claims.

 
Web www.patentalert.com

< Murine zcytor17 ligand polypeptides

< Methods of monitoring treatment of BAFF-R related disease

> Resonance decoupling device for protecting a human or animal body and method of protecting against electromagnetic signals

> Stabilization of enzymes in an emulsion by cross-linking

~ 00600